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Abstract  Adenomyosis  is  a  common  benign  uterine  pathology  that  is  deﬁned  by  the  presence
of islands  of  ectopic  endometrial  tissue  within  the  myometrium.  It  is  asymptomatic  in  one  third
of cases,  but  when  there  are  clinical  signs  they  remain  non-speciﬁc.  It  can  often  be  misdiagnosed
on sonography  as  it  may  be  taken  to  be  multiple  uterine  leiomyomata  or  endometrial  thicken-
ing, both  of  which  have  a  different  prognosis  and  treatment.  Adenomyosis  is  often  associated
with hormone-dependent  pelvic  lesions  (myoma,  endometriosis,  or  endometrial  hyperplasia).
It is  less  commonly  connected  to  infertility  or  obstetrical  complications  and  indeed  any  direct
relationship  remains  controversial.  The  purpose  of  imaging  is  to  make  the  diagnosis,  to  deter-
mine the  extent  of  spread  (focal  or  diffuse,  superﬁcial  or  deep  adenomyosis,  adenomyoma),
and to  check  whether  there  is  any  associated  disease,  in  particular  endometriosis.  The  aim  of
this article  is  to  provide  assistance  in  recognising  adenomyosis  on  imaging  and  to  identify  the
pathologies  that  are  commonly  associated  with  it  in  order  to  guide  the  therapeutic  management
of symptomatic  patients.  Pelvic  ultrasonography  is  the  ﬁrst  line  investigation.  Sonohysterogra-
phy can  assist  with  diagnosis  in  some  cases  (pseudothickening  of  the  endometrium  seen  on
sonography).  MRI  may  be  used  in  addition  to  sonography  to  back  up  the  diagnosis  and  to  look
for any  associated  disease.
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denomyosis  is  a  common  condition,  usually  affecting
ultiparous  women  over  the  age  of  forty.  On  histology,
t  is  characterised  by  the  presence  of  ectopic  endome-
rial  mucosa  within  the  myometrium  (invagination  of
ndometrium  in  the  myometrium  at  a  depth  of  at  least
.5  mm  below  the  basal  layer  of  the  endometrium)  that
eads  to  hypertrophy  of  the  smooth  muscle,  which  con-
rms  the  diagnosis  [1,2]. It  can  be  either  focal  (one  or
everal  foci  in  the  myometrium;  these  are  nodular  in  the
ase  of  adenomyoma)  or  diffuse  (numerous  foci  spread
hroughout  the  myometrium)  and  it  is  often  asymmetric,
redominating  in  the  posterior  uterine  corpus.  Making  the
istinction  between  the  superﬁcial  (simple  thickening  of  the
unctional  zone  seen  on  MRI  or  lesions  that  do  not  extend
eyond  one  third  of  the  depth  of  the  myometrium)  and
eep  forms  (when  lesions  penetrate  deeper  then  one  third
f  the  way  into  the  myometrium)  is  more  controversial.
denomyosis  is  often  associated  with  hormone-dependent
elvic  lesions  (myoma,  deep  pelvic  endometriosis  [DPE],
olyps,  or  endometrial  hyperplasia).  These  could  be  cases  of
‘external’’  adenomyosis,  connected  to  the  lesions  of  deep
elvic  endometriosis  invading  the  myometrium  from  the  out-
ide  inwards.  This  phenomenon  has  already  been  described
or  lesions  found  in  the  rectovaginal  septum,  and  these  are
istologically  similar  to  adenomyosis  [3,4]. Recent  MRI  stud-
es  have  shown  that  adenomyosis  and  endometriosis  are
robably  two  entities  governed  by  a  single  pathophysiologi-
al  and/or  genetic  process.  In  terms  of  the  severity  of  DPE
nd  adenomyosis  lesions  when  they  are  possibly  associated,
 particular  correlation  has  been  found  for  lesions  of  the
ectovaginal  septum  [5,6].
Its  role  in  infertility  is  still  debated:  the  association
etween  adenomyosis  and  sterility  is  poorly  understood
occurring  in  between  1  and  14%  of  the  cases  in  the  liter-
ture)  but  the  frequency  of  infertility  has  not  been  assessed
n  large  studies  [7].  The  theory  of  the  pathophysiology  is
ne  of  uterine  hypermobility  (irregular  and  uncontrolled)
hat  inhibits  the  transfer  of  spermatozoa  from  the  uterus
o  the  fallopian  tubes,  the  mobility  of  the  fertilised  ovo-
yte,  normal  implantation  of  the  embryo,  and  the  ability
f  trophoblasts  to  penetrate  the  myometrium  (preventing
he  development  of  a  functional  placenta).  Another  hypoth-
sis  put  forward  has  been  junctional  zone  dysfunction.
n  parallel,  while  the  relationship  between  deep  pelvic
ndometriosis  and  fertility  is  recognised  by  the  majority
f  authors,  its  mechanism  remains  poorly  elucidated.  The-
ries  include  irregular  ovulation,  transport  abnormalities
n  the  fallopian  tubes,  and  abnormalities  with  fertilisation
r  implantation  [7].  Adenomyosis  is  thought  to  be  a  sig-
iﬁcant  factor  for  infertility  in  endometriosis,  and  its  role
n  this  is  probably  due  to  changes  in  uterine  transport  of
permatozoa  [6].  This  was  the  conclusion  of  a  study  carried
ut  on  34  patients  after  laparoscopic  segmental  colorectal
esection  for  endometriosis  [8,9]. Wang  et  al.  [10]  under-
ined  the  uncertain  relationship  between  infertility  and
ocal  adenomyosis  or  adenomyoma,  while  noting  that  severe
ndometriosis  does  reduce  the  chances  of  successful  treat-
ent  with  medically  assisted  procreation  (MAP)  techniques.
oday,  there  is  no  consensus  on  treatment  for  patients  who
ish  to  become  pregnant,  especially  in  terms  of  restoring
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heir  fertility.  Various  treatment  options  are  used:  hormone
reatment,  focal  surgical  resection,  embolisation  of  uterine
rteries,  and  other  experimental  techniques.
A  number  of  factors  that  encourage  adenomyosis  to
evelop  have  been  found:  the  main  factor  is  having  had
ore  than  one  pregnancy,  but  there  is  also  spontaneous
iscarriage,  ETOP,  curettage,  hysteroscopic  resection  of  the
ndometrium,  uterine  myomectomy,  caesarean  section,  and
aking  Tamoxifen®.  It  is  thought  that  there  could  be  a  genetic
redisposition.  Tobacco  use  is  thought  to  be  a  protective  fac-
or  (probably  due  to  reduced  plasma  levels  of  oestrogens).
Aside  from  the  hyperoestrogenaemia  that  has  been
emonstrated  in  ectopic  endometrial  tissue,  a correlation
as  been  made  between  adenomyosis  and  dysfunctional  reg-
lation  or  abnormally  high  quantities  of  some  HLA2-type
mmune  response  proteins,  without  necessarily  implying
hat  there  is  a  causative  relationship:  interleukin-18  (IL-18)
11]  and  leukaemia  inhibitory  factor  (LIF)  [12]. It  has  been
uggested  that  abnormal  secretion  of  IL-6  [13]  from  endome-
rial  stromal  cells  may  play  a  role  in  forming  the  ectopic
slands  of  endometrial  tissue  in  adenomyosis.  Overexpress-
on  of  cyclooxygenase-2  [14]  (COX-2)  also  seems  to  have  a
igniﬁcant  role  in  the  pathogenesis  and  it  could  be  a  poten-
ial  target  for  the  treatment  or  prevention  of  adenomyosis.
Clinically,  one  third  of  patients  are  asymptomatic  and
hen  there  are  functional  signs,  they  remain  non-speciﬁc,
onsisting  mainly  of  menometrorrhagia,  dysmenorrhoea,
nd  pelvic  pain.  Superﬁcial  adenomyosis  is  thought  to
e  more  commonly  expressed  as  minimally  incapacitating
bnormal  uterine  bleeding,  while  the  deep  form  is  thought
o  involve  more  severe  pain,  disabling  menometrorrhagia,
r  even  dyspareunia.  The  gynaecological  examination  will
ook  for  a  globular  uterus  that  is  painful  on  mobilisation.  In
ractical  terms,  when  there  is  clinical  suspicion  of  adeno-
yosis,  an  ultrasound  scan  of  the  pelvis  should  be  carried
ut  ﬁrst,  and  this  may  be  enough  to  arrive  at  a  positive
iagnosis.  If  doubt  persists  over  diagnosis  (myoma?  Endome-
rial  thickening?)  or  an  associated  disease  is  also  suspected
myoma,  endometriosis),  a  pelvic  MRI  scan  and  sonohys-
erography  may  be  required  to  complete  investigations.
ysterography  is  no  longer  considered  to  be  indicated  in  this
ondition.
maging features of adenomyosis
onography
he  direct  signs  are:
anechoic  subendometrial  microcysts  in  the  myometrium
(around  2—4  mm  in  diameter)  that  can  be  distinguished
from  a  vascular  image  on  Doppler  sonography  because
they  are  not  vascularised  (pathognomonic  sign).  This  cys-
tic  space  is  the  direct  sign  of  the  adenomyosis  lesion  and
it  corresponds  to  ectopic  dilated  endometrial  glands  pos-
itioned  within  the  myometrium  that  may  or  may  not  be
haemorrhagic  (if  they  are,  their  contents  show  greater
echogenicity)  during  and  immediately  post-menstruation;
the  myometrium  has  a  non-homogenous  appearance
combining  hyperechoic  linear  striations  within  the
myometrium,  small  hyperechoic  subendometrial  nodules,
pseudonodular  hypoechoic  zones  with  indistinct  contours
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Figure 1. Sonographic signs of adenomyosis: a, b: globular uterus and asymmetric myometrial walls; c: thickening of the interface between
the myometrium and endometrium; d: subendometrial hyperechoic striations.
Figure 2. Pelvic sonogram, axial (a) and sagittal views (b) of the uterus. Signiﬁcant thickening of the endometrial/myometrial junction
and subendometrial microcysts pointing to diffuse adenomyosis. Thin endometrium (5 mm).
6  G.  Levy  et  al.
Figure 3. Differences in vascularisation between adenomyosis and leiomyoma demonstrated on power Doppler sonography: vascularisation
crosses the hypertrophied myometrium in diffuse adenomyosis (a) as opposed to the peripheral vascular projections in leiomyoma (b).
Figure 4. Diffuse adenomyosis on sonography: comparison between transabdominal and transvaginal sonography in a 43-year old patient
presenting menometrorrhagia: a, b: transabdominal: globular uterus (measuring 10 × 8 × 10 cm), uncertainty over the presence of leiomy-
oma; c, d: transvaginal approach in the same patient: at least one subendometrial microcyst, heterogeneous myometrium, hyperechoic
linear striations within the myometrium, and asymmetric myometrial walls.
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and  no  mass  effect  on  the  endometrium,  and  a  poorly
deﬁned  or  thickened  endometrial-myometrial  junction.
The  indirect  signs  are  those  that  result  from  reactive
hypertrophy  of  the  smooth  muscle  ﬁbres  of  the  myometrium
around  the  ectopic  endometrial  glands  and  they  suggest  that
adenomyosis  is  likely.  The  sonographer  should  look  for:
• the  classic  sign  of  a  uterus  that  is  enlarged,  soft,  and
rounded  but  has  regular  contours  (as  opposed  to  the
uterus  with  multiple  leiomyomata,  which  has  relatively
irregular  contours  that  are  deformed  by  the  ﬁbroids);
• asymmetrical  myometrial  walls  (a  sign  of  muscular  hyper-
trophy);
• linear  pattern  of  vascularisation  on  Doppler  sonography,
crossing  the  myometrium  within  the  adenomyosis  lesions
(as  opposed  to  the  peripheral  and  central  vascularisation
seen  in  leiomyoma)  (Figs.  1—3).
The  limitations  of  both  transabdominal  and  transvaginal
(Fig.  4)  for  positively  diagnosing  adenomyosis  have  been
studied  [15]. Taking  as  transabdominal  sonography  sign:
a  large  uterus  regular,  possibly  asymmetric,  more  or  less
heterogeneous,  without  individualized  myoma,  with  pos-
sible  intra  myometrial  cystic  images,  the  transabdominal
sonography  had  a  poor  sensitivity  of  30%  but  a  good  speci-
ﬁcity  of  97%.  The  combination  of  both  approaches  increased
the  accurency  diagnosis.  The  presence  of  subendometrial
cysts  was  the  most  speciﬁc  sonographic  sign  for  diagnosis.
Myometrial  linear  striations  were  correlated  to  hypertro-
phy  of  the  myometrium.  The  transvaginal  sonography  may
also  be  limited  in  the  case  of  large  uterus,  heterogeneous
and  hypoechoic  (uterine  leiomyomata  and/or  adenomyosis)
default  in  depth-study;  the  use  of  MRI  appears  to  be  useful.
Differential  diagnosis:
• multiple  uterine  leiomyomata  is  the  main  differential
diagnosis  for  diffuse  adenomyosis  on  sonography  (Table  1);
• the  use  of  Doppler  sonography  means  that  external
myometrial  vessels  are  not  mistaken  for  the  cystic  spaces
seen  in  adenomyosis;
• cystic  glandular  endometrial  hypertrophy  is  more  difﬁcult
to  differentiate  from  the  subendometrial  cysts  seen  in
adenomyosis  using  sonography:  in  these  cases  MRI  may
prove  to  be  useful.  It  is  worth  noting  that  Tamoxifen®
encourages  three  types  of  endometrial  change:  thickening
Table  1  Making  the  differential  diagnosis  between  ade-
nomyosis  and  leiomyoma  on  sonography.
Leiomyoma ±  Associated  with
adenomyosis
Deﬁned  margins Poorly  deﬁned  margins
Round Variable  shape
Mass  effect No  mass  effect
Calciﬁcations  ± No calciﬁcation
Attenuation  with  edge
shadowing
Multiple  foci  of
attenuation
Peripheral  vascularisation  Rectilinear  vascularisation
pattern  crossing  the
hypertrophied
myometrium
[
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due  to  cancer,  adenomyosis  and  cystic  glandular  hypertro-
phy  (Fig.  5);
endometrial  thickening  can  also  mimic  diffuse  adeno-
myosis.  If  this  is  suspected,  sonohysterography  may  be
useful  for  diagnosis  (Fig.  6).
onohysterography
his  technique  uses  a  saline-infusion  to  opacify  the  suben-
ometrial  cysts  and  it  can  be  used  to  differentiate  focal
r  superﬁcial  adenomyosis  from  a  pseudothickening  of
he  endometrium  seen  on  sonography  (this  is  suspicious,
or  example,  for  carcinoma  in  a  postmenopausal  patient)
Fig.  6).  If  adenomyosis  is  suspected  on  sonohysterogra-
hy,  the  diagnosis  is  conﬁrmed  on  MRI  in  96%  of  cases  [16].
his  examination  performs  by  demonstrating  that  there  is
ontinuity  between  the  subendometrial  cystic  spaces  char-
cteristic  of  adenomyosis  and  the  endometrial  cavity  [17].
he  superﬁcial  sites  remain  in  continuity  with  the  cavity
hile  the  deep  sites  have  usually  lost  all  continuity  with
he  uterine  cavity.
ysterography
his  is  no  longer  used  for  positive  diagnosis  because  it
s  neither  sensitive  nor  speciﬁc.  When  used  for  primary
r  secondary  investigations  into  fertility  in  addition  to  a
elvic  ultrasound  scan,  ﬁndings  can  nonetheless  be  made
f  spicules  measuring  1—4  mm  in  length,  extending  from  the
ndometrium  towards  the  myometrium,  or  a  rigid  or  dilated
terine  horn  with  the  ‘‘tuba  erecta’’  image  (Fig.  7).
T scanning
T  is  not  suitable  for  diagnosing  adenomyosis.  It  is  possi-
le  that  CT  could  suggest  this  diagnosis  based  on  ﬁnding  a
lobular  uterus.  In  one  study,  16  patients  with  adenomyosis
emonstrated  on  MRI  had  needed  a  CT  scan  for  another  rea-
on,  and  on  a  second  reading  it  was  found  that  out  of  eight
atients,  the  diagnosis  could  have  been  made  on  the  CT  scan
ut  it  had  not  been  put  forward  on  the  initial  assessment
18].
RI [19]
elvic  MRI  is  superior  to  transvaginal  sonography  in  terms  of
peciﬁcity  and  sensitivity  for  both  focal  and  diffuse  adeno-
yosis  [20—22]. There  is  some  overlap  between  the  signs
ound  on  MRI  and  on  sonography  [23,24]  (Table  2):
globular  uterus  with  regular  contours
asymmetrical  thickening  of  the  myometrial  walls  (more
common  at  the  posterior  wall)
thickening  of  the  JZ  ≥  12  mm  [25]  (Fig.  8).  Thresholds  for
measurement  have  been  proposed  (≤  8  mm  or  ≥  12  mm
with  a  zone  of  uncertainty  between  8  and  12  mm)  but  none
is  able  to  conﬁrm  or  exclude  adenomyosis  (studies  show
varying  sensitivity  and  speciﬁcity)  [25]
greatest  JZ  thickness  to  total  myometrium  ratio  >  40—50%
(connected  to  muscular  hypertrophy)
foci  of  high  signal  intensity  running  alongside  the
endometrium  on  T2  and  sometimes  also  T1-weighted
images  that  persist  on  Fat-Sat  (FS).  These  correspond
8  G.  Levy  et  al.
Figure 5. Glandular and cystic hypertrophy of the endometrium (a pitfall encountered on sonography): a—c: features on transabdominal
a tic re
s nce.
o
•nd then transvaginal sonography: diffuse adenomyosis? d, e: magne
equences; f: plus gadolinium-enhanced sagittal T1-weighted seque
to  the  dilated  ﬂuid-ﬁlled  and  possibly  haemorrhagic
endometrial  glands  (Figs.  9  and  10).
There  are  pitfalls  on  MRI  that  it  is  important  to  be  aware
f  because  JZ  thickness  varies  [25,26]:
•
•sonance imaging of the same patient, sagittal and axial T2-weighted
depending  on  the  menstrual  cycle  (thickest  between
day  8  and  day  16,  variable  during  menstrua-
tion);
during  the  menopause:  thinner  or  possibly  absent;
during  pregnancy:  thins  until  it  disappears;
An  update  on  adenomyosis  9
Figure 6. Sonohysterography carried out after sonography in a 54-year old patient presenting postmenopausal metrorrhagia: a—c: globular
uterus, subendometrial cysts, and suspected endometrial thickening (15 mm) on sonography: endometrial cancer? d—f: sonohysterography,
 solu
c
t
a
a
scatheter balloon at the cervix and intracavitary injection of saline
adenomyosis, thin atrophic endometrium (< 5 mm).
• with  age:  thickens  up  to  the  age  of  50  and  then  thins;
• with  use  of  the  contraceptive  pill  and  GnRH  agonists:  thins
(Fig.  11);
• with  myometrial  contractions:  pseudothickening  of  the  JZ
(Figs.  12  and  13).The  MRI  must  therefore  be  carried  out  by  experi-
enced  radiologists  when  the  patient  is  not  menstruating.
Rapid  T2  sequences  can  be  repeated  and  should  be
t
e
4
ttion: opaciﬁcation of the subendometrial cysts due to superﬁcial
orrelated  with  other  views  in  case  of  uterine  contrac-
ions.  The  standard  MRI  protocol  combines  sagittal  and
xial  views  on  T2-weighted  and  spin  echo  sequences,
nd  T1-weighted  axial  sequences  with  and  without  fat-
aturation.  In  the  rare  cases  when  embolisation  is  planned,
he  examination  can  be  completed  by  dynamic  gadolinium-
nhanced  sagittal  sequences  every  5  to  20  seconds  for  2  to
 minutes  and  later  views  taken  after  the  gadolinium  injec-
ion.
10  G.  Levy  et  al.
Figure 7. Hysterography: subendometrial adenomyotic spicules and ‘‘Tuba Erecta’’ image.
F ng (sa
u
c
•
•
•igure 8. Deep diffuse adenomyosis on magnetic resonance imagi
terus with regular contours.
It  is  important  to  also  look  for  the  commonly  associated
onditions  on  MRI,  making  use  of  clinical  information:
adenomyosis  and  leiomyomata  (Fig.  14);
adenomyosis  and  deep  pelvic  endometriosis  (Figs.  15—17);
differential  diagnoses:
◦ diffuse  thickening  of  the  JZ  during  menstruation  or  of
hormonal  origin,
◦ myoma:  round,  well-circumscribed,  low  T2  signal
intensity.  MRI  is  more  sensitive  than  sonography  for
Table  2  Standardised  criteria  for  the  positive  diagnosis
of  adenomyosis  on  magnetic  resonance  imaging.
JZ  ≥  12  mm
Max  ratio  >  40—50%
Foci  of  high  T2  signal  intensity  ±  high  T1  FS  signal
intensity
JZ: junctional zone; FS: Fat-Sat.gittal T2-weighted sequence): thickened junctional zone, globular
identifying  adenomyosis  with  concomitant  myomata
[20],
◦ myometrial  contractions:  transient,  wedge-shaped
areas  of  low  T2  signal  intensity,
◦ metastases  (rare):  low  T2  signal  intensity,  with  a  glob-
ular  uterus,  primary  breast  or  gastrointestinal  cancer,
◦ cystic  endometrial  hyperplasia,
◦ endometrial  carcinoma:  comparison  with  biopsies  is
required  because  it  can  be  difﬁcult  to  judge  the  depth
of  the  myometrial  invasion  on  MRI  when  there  are
associated  adenomyosis  lesions  (Fig.  18).  An  endometri-
oid  adenocarcinoma  that  extends  into  an  underlying
adenomyosis  is  thought  to  be  more  invasive,  and  the
probable  mechanism  of  this  is  an  increase  in  the  sur-
face  of  the  interface  with  the  adjacent  myometrium.
These  tumours  are  not  only  thought  to  be  likely
to  invade  the  myometrium  to  a  greater  extent,  but
they  also  encourage  invasion  into  the  deepest  half  of
the  myometrium  (>  50%),  and  beyond  this  threshold
there  is  an  increased  risk  of  lymph  node  metastases
[27,28],
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Figure 9. Correlations between sonography and magnetic resonance imaging: globular uterus due to diffuse adenomyosis. Subendometrial
cysts presenting high signal intensity on T2-weighted sequences, some of which are haemorrhagic exhibiting high signal intensity on T1-
weighted FS sequences: a, b: pelvic sonogram; c: sagittal T2-weighted magnetic resonance imaging sequence; d: axial T2-weighted sequence;
e: Axial T1-weighted FS sequence.
12  G.  Levy  et  al.
Figure 10. Deep diffuse adenomyosis on magnetic resonance imaging: subendometrial ﬂuid-ﬁlled cysts exhibiting high signal intensity
on T2-weighted images, non-haemorrhagic: a: sagittal T2-weighted sequences; b, c: axial T2-weighted sequences; d: sagittal T1-weighted
sequence; e: gadolinium-enhanced axial T1-weighted FS sequence.
An  update  on  adenomyosis  
Figure 11. On gonadotropin releasing hormone, the endometrium
appears atrophied and the uterus showing menopausal features
exhibits overall low signal intensity on T2-weighted sequences:
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Figure 12. Uterine contractions (can be mistaken for junctional zone th
of the myometrium with low T2 signal intensity on both sagittal and axi
rapid sagittal sequence: uterine contractions.13
◦ abscess  secondary  to  adenomyosis  mimicking  a  malig-
nant  tumour  [29].
peciﬁc cases [30]
imple adenomyoma
his  is  a localised  nodular  lesion  that  is  often  poorly  deﬁned
ith  extensive  muscle  response  that  may  be  intramyome-
rial,  subserosal,  and  possibly  even  intracavitary.  It  consists
f  a  local  coalescence  of  adenomyotic  glands  and  can  lead  to
 mass  effect  on  the  endometrium.  On  MRI,  it  produces  rel-
tively  non-homogenous  low  signal  intensity  on  T2-weighted
mages.  It  remains  difﬁcult  to  differentiate  from  leiomyoma
ut  if  foci  of  high  signal  intensity  are  seen  on  T2-weighted
mages,  then  this  is  suggestive  of  adenomyoma  (Fig.  19).
oth  adenomyoma  and  leiomyoma  can  cause  a  signiﬁcant
ass  effect  on  the  uterine  cavity  and  can  even  producentracavitary  growth  (Figs.  20  and  21).  This  lesion  is  not
ncapsulated,  meaning  that  there  is  no  straightforward  sur-
ical  cleavage  plane.
ickening on magnetic resonance imaging): a, b: striped appearance
al views; c: areas of low T2 signal intensity disappear on the ultra
14  G.  Levy  et  al.
Figure 13. Another example of uterine contractions (can be mistaken for junctional zone thickening on magnetic resonance imaging): a,
b: heterogeneous myometrium with areas of low T2 signal intensity on the sagittal view, underlying adenomyosis? c: sequence repeated a
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gew minutes later: homogenous myometrium, uterine contractions.
aemorrhagic cystic adenomyosis
‘‘adenomyotic  cyst’’)
ystic  adenomyosis  occurs  when  there  is  bleeding  into  an
ctopic  island  of  endometrial  glandular  tissue  that  is  totally
r  partially  surrounded  by  myometrium.  Images  of  intramy-
metrial  cysts  present  slightly  echogenic  contents  with  or
ithout  a  nodular  appearance  when  there  is  adenomyoma.
hey  vary  in  size.  They  are  normally  situated  within  the
all,  although  they  may  sometimes  be  submucosal  or  sub-
erosal.  On  MRI,  the  ﬂuid  content  is  haemorrhagic  exhibiting
igh  signal  intensity  on  T1-weighted  images  that  persists  on
S,  while  showing  variable  signal  intensity  on  T2-weighted
mages  (Figs.  22  and  23).  The  ﬁnding  of  low  signal  inten-
ity  on  T2-weighted  images  from  the  wall  combined  with
aemorrhagic  contents  is  suggestive  of  cystic  adenomyosis.
 ﬂuid-ﬂuid  level  is  possible.
ascularisation
n  the  absence  of  objective  published  data,  it  seems
hat  adenomyosis  presents  variable  vascularisation
Figs.  19  and  20).
ecidualisation of adenomyosis lesions
his  process  entails  an  increase  in  pre-existing  adenomyosis
esions  due  to  pregnancy,  which  may  be  explained  by  the
ormonal  effects  of  pregnancy  on  the  ectopic  endometrium
Fig.  24).
reatmentf  the  patient  is  asymptomatic  no  treatment  is  indi-
ated.  If  symptoms  are  present,  there  are  several  potential
reatment  options  [31,32]:  medical  (hormonal)  or  surgical
t
[
r
creatment  (conservative  or  radical).  A  treatment  will  be  cho-
en  based  on  the  patient’s  symptomatology  and  whether  she
s  interested  in  future  child  bearing  [31].
irst line medical treatment
ral  progesterones  such  as  dydrogesterone  are  often  used
o  treat  premenopausal  menometrorrhagia  that  is  probably
aused  by  adenomyosis.  They  cause  endometrial  atrophy
ue  to  their  anti-oestrogen  action  but  that  do  not  have
ny  effect  on  cells  involved  in  adenomyosis  that  are  hor-
one  resistant.  They  are  an  effective  treatment  for  pain,
ysmenorrhoea,  and  other  symptoms  in  endometriosis  but
ne  study  [33]  emphasised  the  lack  of  reliable  data  to
alidate  their  use  in  adenomyosis.  Functional  signs  reap-
ear  after  six  months  in  30  to  50%  of  cases  [34]. The
evonorgestrel-releasing  intrauterine  device  (Mirena®)  is  the
nly  effective  and  well-tolerated  treatment  for  menometr-
rrhagia  in  adenomyosis  [32]: it  markedly  reduces  uterine
nlargement,  pain,  and  the  signiﬁcance  of  dysmenorrhoea
35].  After  three  years,  tachyphylaxis  has  been  demon-
trated  and  its  replacement  is  suggested  [36]. NSAIDs  are
lso  used.  GnRH  agonists  cause  hypoestrogenism  and  there-
ore  reduce  uterine  enlargement,  JZ  thickness,  and  the
ndometrial  deposits  that  cause  dysmenorrhoea.  They  can
e  used  preoperatively  in  order  to  make  it  easier  to  carry
ut  resections  of  sites  of  adenomyosis  when  a  conserva-
ive  approach  is  used,  or  to  reduce  uterine  size  before
ysterectomy.  They  can  also  be  prescribed  to  women  who
re  interested  in  future  child  bearing  and  they  may  or
ay  not  be  combined  with  surgery  (adenomyoma  resection)
32].  Danazol  is  less  commonly  used  because  it  has  andro-
enic  side  effects,  and  no  clinical  studies  have  proved  it
o  be  effective  in  adenomyosis  [32]. In  an  in  vitro  model
13],  danazol  and  medroxyprogesterone  acetate  (MPA)
educed  secretion  of  interleukin-6  from  endometrial  stromal
ells.
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Figure 14. Deep adenomyosis of the anterior myometrium on magnetic resonance imaging with haemorrhagic foci, associated with a
number of leiomyomata (here they are intracavitary and in the wall of the posterior isthmus): a, b: sagittal T2-weighted sequence; c: axial
1-wei
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bT2-weighted sequence; d: axial T1-weighted sequence; e: axial T
sequence.
Embolisation of uterine arteries
Consideration  is  made  of  whether  this  procedure  is  indi-
cated  on  a  case-by-case  basis.  It  consists  of  selective
embolisation  of  a  uterine  artery  on  each  side  using
non-calibrated  microparticulate  PVA  (polyvinyl  alcohol)
or  a  calibrated  microparticulate  agent  (trisacryl  micro-
spheres,  500—700  m),  with  or  without  a  gelatin  sponge
(Spongel® or  Curaspon®)  [37—39]. The  clinical  results
show  short-term  resolution  of  symptoms  (particularly
[
rghted FS sequence; f: gadolinium-enhanced sagittal T1-weighted
or  menorrhagia,  but  less  so  for  pain)  [40]. Medium
nd  long-term  efﬁcacy  varies  depending  on  the  study
41,42]  (approximately  50%  long-term  success)  but  there
s  signiﬁcant  recurrence  of  symptoms  after  two  years
ave  passed  [43]. A  repeat  treatment  or  a  hysterec-
omy  may  be  required.  Bilateral  uterine  artery  ligation
y  abdominal  endoscopy  seems  to  be  less  effective
32].
MRI  can  show  post-treatment  changes  (Figs.  25  and  26):
educed  uterine  size,  decreased  JZ  thickness,  and  full
16  G.  Levy  et  al.
Figure 15. Deep diffuse adenomyosis on magnetic resonance imaging (thickened junctional zone and foci of high T2 signal intensity)
associated with deep pelvic endometriosis of the torus uterinus invading the myometrium (foci of high signal intensity on T1-weighted FS
images): a, b: sagittal and axial T2-weighted sequences; c, d: axial T1-weighted FS sequences.
Figure 16. Focal adenomyosis (normal junctional zone on the left image/thickened on the right with foci of high T2 signal intensity).
L  T2 si
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cesions associated with anterior and posterior DPE with foci of high
agittal T2-weighted sequence; b: Coronal T2-weighted sequence.
r  partial  infarction  of  the  lesions  with  non-vascularised
reas  of  low  signal  intensity  on  T2-weighted  images
44,45].  There  is  not  usually  any  fall  in  the  maximum
Z-myometrium  ratio.  However,  only  limited  numbers  of
a
a
ignal intensity at the uterine surface (‘‘external adenomyosis’’): a:
ases  have  been  described  combining  both  adenomyosis
nd  leiomyoma,  so  the  improvement  in  symptoms  may  be
ttributable  to  treatment  of  either  one  of  these  abnormal-
ties.
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Figure 17. Deep diffuse adenomyosis that is predominantly posterior with foci of high T2 signal intensity associated with interstitial leiomy-
omata of the anterior and right posterolateral uterine corpus, deep pelvic endometriosis of the torus uterinus, and bilateral endometriotic
cysts: a: sagittal T2-weighted sequence; b: axial T2-weighted sequence.
Figure 18. Adenomyosis and endometrial cancer: does the adenomyosis limit the spread of the cancer within the myometrium? a, b:
sagittal T2-weighted magnetic resonance imaging sequence: thickened junctional zone, subendometrial microcysts; c: sagittal sonographic
view: is there invasion of the anterior subendometrial microcyst?
18  G.  Levy  et  al.
Figure 19. Adenomyoma of the right uterine corpus with a nodular appearance and subendometrial microcysts. Note the hypervascularity
shown on MRI (d): a, b: sagittal and axial T2-weighted sequences; c, d: contrast-enhanced sagittal and axial T1-weighted Fat-Sat sequences;
e
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p: transvaginal sonogram of the same patient. Note the microcysts.
urgical treatment
urgery  may  be  radical  (hysterectomy:  HST)  or  conservative
hysteroscopy  and  endometrial  curettage,  adenomyomec-
omy,  resection  of  the  site  of  adenomyosis  with  or  without
reatment  for  associated  endometriosis).  The  age  of  the
atient  and  whether  she  is  interested  in  future  child  bearing
r
s
p
eill inﬂuence  the  type  of  surgery  chosen.  The  choice
etween  a  total  and  subtotal  HST  is  made  based  princi-
ally  on  the  health  of  the  cervix,  pouch  of  Douglas,  and
ectovaginal  septum  [32]. The  decision  on  whether  to  con-
erve  the  adnexal  structures  depends  on  age,  and  the
resence  of  endometrioma  or  associated  deep  peritoneal
ndometriosis.
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Figure 20. Initial suspicion of endometrial cancer on computed tomography (CT) (a). On sonography (b, c) and magnetic resonance
imaging (MRI) (d), it in fact appears to be an anterior adenomyoma: nodular appearance within the myometrium, isosignal intensity from
the junctional zone with foci of high T2 signal intensity, and a moderate mass effect on the cavity. Note the hypervascularity shown on MRI
(e): a: sagittal plane CT; b, c: sonography views of the uterus; d: sagittal T2-weighted MRI sequences; e: plus contrast-enhanced T1-weighted
sequences treatment for associated.
u
pExperimental US guided treatments
One  case  of  focal  adenomyosis  treated  with  ultrasound-
guided  aspiration  and  sclerotherapy  with  intracavitary
alcohol  instillation  [46]  has  been  reported  for  a  recurrent
symptomatic  lesion.
o
s
mThe feasibility  of  laparoscopic  high-intensity  focused
ltrasound  (HIFU)  ablation  has  been  studied  in  seven
atients  with  focal  adenomyosis  [47]. Anatomical  pathol-
gy  investigations  conﬁrmed  that  thermal  ablation  of  the
ites  of  adenomyosis  had  been  successful,  with  healthy
argins.
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Figure 21. Intracavitary polypoid adenomyoma on sonography and magnetic resonance imaging: a, b: sagittal and axial sonography views
of the uterus; c, d: sagittal and coronal T2-weighted sequences; e, f: sagittal T1-weighted Fat-Sat sequences before and after contrast
enhancement.
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Figure 22. Haemorrhagic cystic adenomyoma on magnetic resonance imaging: peripheral halo of low T2 signal intensity and central
haemorrhagic ﬂuid contents exhibiting high signal intensity on T1-weighted images that persist with fat-saturation: a: sagittal T2-weighted
view; b: sagittal T1-weighted view; c: sagittal T1-weighted Fat-Sat view.
Figure 23. Haemorrhagic cystic adenomyoma of the left uterine horn on a bicornate uterus with a double cervix seen on magnetic
resonance imaging: a: coronal T2-weighted view; b: axial T1-weighted view; c: axial T1-weighted Fat-Sat view.
22  G.  Levy  et  al.
Figure 24. Decidualisation of adenomyosis lesions: a: right uterine horn, sagittal sonographic view: endometrium in a pregnant woman
and adenomyosis lesions. Correlates on magnetic resonance imaging to: adenomyosis of the right uterine horn and intrauterine pregnancy
in the rudimentary left horn; b: sagittal T2-weighted sequence; c: axial T2-weighted sequence.
Figure 25. Adenomyosis before and after embolisation shown on two successive monitoring magnetic resonance imaging scans, sagittal T2-
weighted sequences (a—c): reduced thickness of the junctional zone and zone of post-embolisation change in the uterine fundus exhibiting
low T2 signal intensity.
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Figure 26. Magnetic resonance imaging monitoring of an embolised adenomyoma, sagittal views: adenomyoma before embolisation: a: T2-
weighted sequence; b: contrast-enhanced T1-weighted sequence. After embolisation: reduced size of the adenomyoma and the microcysts
with post-embolisation change exhibiting low T2 signal intensity, non-vascularised; c: T2-weighted sequence; d: contrast-enhanced T1-
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Conclusion
Adenomyosis  is  a  common  condition  that  is  asymptomatic  in
one  third  of  cases,  although  in  others  it  can  cause  dysmen-
orrhoea  and/or  menometrorrhagia.
The  purpose  of  imaging  is  to  make  the  diagnosis,  to
determine  the  extent  of  disease  spread,  and  to  look  for
any  associated  pathologies,  especially  endometriosis  in  an
infertile  patient.
A transvaginal  pelvic  sonogram  is  the  ﬁrst  line  inves-
tigation.  Sonohysterography  may  be  useful  for  diagnosis
in  some  speciﬁc  kinds  of  cases.  MRI  is  the  second  line
investigation  to  carry  out,  and  it  offers  the  best  perfor-
mance  when  there  is  any  doubt  over  diagnosis  and  in
terms  of  looking  for  any  of  the  pathologies  associated  with
adenomyosis.isclosure of interest
he  authors  declare  that  they  have  no  conﬂicts  of  interest
oncerning  this  article.
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